Tyra Biosciences ($TYRA) Insider Trading & Smart Money Activity

Tyra Biosciences, Inc. · Biotechnology · Latest filing Jun 17, 2026

Tyra Biosciences, Inc. ($TYRA) has 1 13F position change and 3 analyst ratings on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
1
Analyst ratings on file
3

TYRA insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 1 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All TYRA insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Jones Trading Reiterates to buy PT $56 +4.5%+10.5% Read
Analyst B of A Securities Reiterates to buy PT $42 +14.4%+28.8% Read
Analyst B of A Securities Reiterates to buy PT $42 +14.4%+28.8% Read
13F Farallon Capital Management Added +1.51M sh $114.37M -12.3%-22.9% —

1W / 1M / 6M = how TYRA moved from the trade or filing date.

Institutions moving TYRA (13F)

Analyst ratings on TYRA

DateFirmActionRatingPrice target1W1M6MStory
Jones Trading Reiterates buy $56 +4.5%+10.5% Read
B of A Securities Reiterates buy $42 +14.4%+28.8% Read
B of A Securities Reiterates buy $42 +14.4%+28.8% Read

Frequently asked questions

Which institutions changed their TYRA positions?

Recent 13F filers moving the stock include Farallon Capital Management.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text